NPI: 1114033628 · JOHNSON CITY, TN 37604 · General Acute Care Hospital · NPI assigned 08/21/2006
Authorized official HILTON, SHANE controls 20+ related entities in our dataset. Read more
| Authorized Official | HILTON, SHANE (EVP/CFO) |
| NPI Enumeration Date | 08/21/2006 |
Other providers sharing the same authorized official: HILTON, SHANE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 31,973 | $1.66M |
| 2019 | 31,163 | $1.45M |
| 2020 | 14,564 | $812K |
| 2021 | 17,612 | $1.07M |
| 2022 | 18,384 | $1.30M |
| 2023 | 17,288 | $1.05M |
| 2024 | 14,521 | $798K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 14,929 | 13,394 | $3.27M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10,293 | 9,139 | $2.93M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 6,301 | 5,935 | $939K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 10,545 | 9,432 | $324K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,602 | 1,430 | $143K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 19,860 | 17,331 | $96K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,198 | 1,082 | $89K |
| 80053 | Comprehensive metabolic panel | 15,844 | 13,865 | $58K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,422 | 3,943 | $39K |
| 84484 | 2,731 | 2,163 | $34K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,608 | 3,819 | $19K |
| 83690 | 3,494 | 3,165 | $18K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,269 | 1,907 | $18K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 162 | 155 | $16K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,318 | 3,911 | $16K |
| 36415 | Collection of venous blood by venipuncture | 9,497 | 8,082 | $13K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 28 | 27 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 919 | 847 | $9K |
| 0001A | 355 | 272 | $9K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,809 | 858 | $7K |
| 71046 | Radiologic examination, chest; 2 views | 1,263 | 1,186 | $6K |
| 0002A | 222 | 171 | $6K | |
| 81025 | 1,747 | 1,640 | $6K | |
| 83735 | 1,322 | 1,109 | $5K | |
| 81001 | 6,340 | 5,711 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,065 | 1,800 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 134 | 127 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | 154 | 132 | $4K |
| 84703 | 618 | 575 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 223 | 198 | $4K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 14 | 12 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 422 | 412 | $3K |
| 71045 | Radiologic examination, chest; single view | 1,063 | 921 | $2K |
| 87077 | 730 | 706 | $2K | |
| 94761 | 636 | 272 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 71 | 66 | $2K |
| 81003 | 2,880 | 2,617 | $2K | |
| G0378 | Hospital observation service, per hour | 16 | 12 | $2K |
| 0071A | 52 | 52 | $2K | |
| 87088 | 233 | 214 | $1K | |
| 85027 | 340 | 286 | $1K | |
| 85379 | 116 | 106 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 328 | 310 | $1K |
| 87040 | 164 | 80 | $909.51 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,784 | 2,488 | $880.12 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 15 | 14 | $667.03 |
| 85610 | 352 | 321 | $616.61 | |
| 83880 | 63 | 52 | $572.43 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 58 | 50 | $569.25 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 112 | 104 | $376.08 |
| 83605 | 89 | 76 | $328.62 | |
| 0003A | 14 | 14 | $320.00 | |
| 85730 | 97 | 86 | $224.90 | |
| 73630 | 29 | 24 | $161.68 | |
| 87081 | 13 | 13 | $134.08 | |
| 72100 | 16 | 14 | $126.10 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 23 | 20 | $118.15 |
| 82565 | 45 | 40 | $93.66 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 227 | 212 | $60.33 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 44 | 41 | $51.05 |
| 87186 | 12 | 12 | $44.76 | |
| J2704 | Injection, propofol, 10 mg | 156 | 129 | $23.87 |
| J7030 | Infusion, normal saline solution , 1000 cc | 901 | 783 | $22.67 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 53 | 41 | $7.55 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,852 | 3,518 | $6.38 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 12 | 12 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 150 | 133 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 13 | 12 | $0.00 |
| 96376 | 23 | 12 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 15 | 12 | $0.00 |